3P Biopharmaceuticals is a leading European-based Contract Development and Manufacturing Organization (CDMO) specializing in the process development and GMP (Good Manufacturing Practices) manufacturing of biological products, including new biological entities (NBEs), biosimilars, and advanced therapies like cell therapy products and viral vectors. They offer a complete range of services from early-stage development to commercial supply, supporting clients worldwide in bringing innovative biopharmaceutical treatments to patients.
Serves as the central hub for research and development, GMP manufacturing of biologics and cell therapies, quality control, corporate administration, and business development.
State-of-the-art GMP-compliant manufacturing suites for microbial and mammalian cell cultures, advanced analytical laboratories, and dedicated facilities for cell therapy and viral vector production.
Emphasizes scientific excellence, collaboration, customer-focus, and a commitment to quality and innovation. Fosters a dynamic environment for skilled professionals in biotechnology, valuing teamwork and continuous improvement.
Strategically located in Europe, the Navarra facility enables 3P to serve a global client base, contributing significantly to the advancement and availability of biopharmaceutical treatments. It is central to Spain's growing biotech industry.
While headquartered and operating its primary manufacturing facilities in Spain, 3P Biopharmaceuticals serves a global clientele across Europe, North America, and Asia. They support international pharmaceutical and biotech companies in their drug development and commercialization efforts through expert process development, GMP manufacturing, and analytical services for biologics and advanced therapies.
Parque Industrial Mocholí, Calle C, Nº 4
Noáin
Navarra
Spain
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, 3P Biopharmaceuticals' leadership includes:
3P Biopharmaceuticals has been backed by several prominent investors over the years, including:
No major publicly announced C-suite executive hires or departures have been identified for 3P Biopharmaceuticals in the last 12 months (as of late 2023/early 2024). The current leadership team appears stable.
Discover the tools 3P Biopharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
3P Biopharmaceuticals likely uses a standard corporate email format, often combining elements of an employee's name with the company domain '3pbio.com'. A common pattern observed or predicted is the first initial followed by the last name.
[first_initial][last]@3pbio.com
Format
dmolero@3pbio.com
Example
75%
Success rate
3P Biopharmaceuticals • April 23, 2024
3P Biopharmaceuticals and Sealife Biotech are reinforcing their collaboration to advance SLB201, a promising first-in-class anticancer drug candidate, by scaling up its manufacturing process for upcoming clinical trials....more
3P Biopharmaceuticals • March 5, 2024
3P Biopharmaceuticals announced its participation in DCAT Week 2024 in New York, highlighting its commitment to engaging with industry leaders and showcasing its CDMO capabilities in biologics and advanced therapies....more
3P Biopharmaceuticals • January 16, 2024
3P Biopharmaceuticals participated in Advanced Therapies Week in Miami, January 16-19, 2024, sharing insights and expertise in the development and manufacturing of cell and gene therapies....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including 3P Biopharmaceuticals, are just a search away.